Which are the causes of Adult Polyglucosan Body Disease (APBD)?

Adult Polyglucosan Body Disease (APBD) is a rare genetic disorder that affects the nervous system. It is caused by mutations in the glycogen branching enzyme 1 (GBE1) gene, which is responsible for breaking down glycogen, a complex sugar molecule that serves as a storage form of glucose in the body.

The primary cause of APBD is a deficiency in the glycogen branching enzyme, which leads to the accumulation of abnormal glycogen deposits in various tissues, particularly in nerve cells. These deposits, known as polyglucosan bodies, disrupt normal cellular function and impair the transmission of nerve signals.

APBD is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated GBE1 gene (one from each parent) to develop the disease. If both parents are carriers of the mutated gene, each child has a 25% chance of inheriting the disorder.

While the exact mechanisms underlying the development of APBD are not fully understood, several factors contribute to the manifestation of the disease. One important factor is the age-related decline in glycogen metabolism. As individuals age, the efficiency of glycogen breakdown decreases, making them more susceptible to the accumulation of abnormal glycogen deposits.

Another contributing factor is the tissue-specific expression of the glycogen branching enzyme. The enzyme is predominantly expressed in the nervous system, explaining why APBD primarily affects nerve cells. The specific regions of the nervous system affected by the disease determine the range of symptoms experienced by individuals.

Genetic modifiers may also play a role in the variability of APBD symptoms. These modifiers are other genes that can influence the severity and progression of the disease. Variations in these genes can either exacerbate or mitigate the effects of the GBE1 gene mutation.

It is important to note that APBD is a progressive disorder, meaning that symptoms worsen over time. The age of onset and the rate of disease progression can vary widely among affected individuals, even within the same family.

In conclusion, Adult Polyglucosan Body Disease is primarily caused by mutations in the GBE1 gene, leading to a deficiency in the glycogen branching enzyme and subsequent accumulation of abnormal glycogen deposits in nerve cells. Age-related decline in glycogen metabolism, tissue-specific expression of the enzyme, and genetic modifiers also contribute to the development and progression of the disease.